Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Scarlett

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Advanced Drug Delivery Reviews|September 23, 2003
Pegvisomant in the treatment of acromegalyC Parkinson, J A Scarlett, P J Trainer
The American Journal of Physiology|July 1, 1982
Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitusJ M Olefsky, O G Kolterman, J A Scarlett
Annals of Internal Medicine|September 15, 1989
Amiprilose hydrochloride for rheumatoid arthritisW G Riskin, D B Gillings, J A Scarlett
The American Journal of Clinical Nutrition|December 1, 1976
Acute effect of ascorbic acid infusion on carbohydrate toleranceJ A Scarlett, A Zeidler, H Rochman, et al.
The American Journal of Medicine|January 1, 1979
Behçet's syndrome. Report of a case associated with pericardial effusion and cryoglobulinemia treated with indomethacinJ A Scarlett, M L Kistner, L C Yang
The American Journal of Clinical Nutrition|August 1, 1982
Comparison of the metabolic responses to fructose and sucrose sweetened foodsP A Crapo, J A Scarlett, O G Kolterman
The Journal of Clinical Endocrinology and Metabolism|August 18, 2000
Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogsV S Herman-Bonert, K Zib, J A Scarlett, et al.
Diabetes|May 20, 1999
Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in miceA Flyvbjerg, W F Bennett, R Rasch, et al.
Diabetes|October 1, 1982
In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in manR S Gray, J A Scarlett, J Griffin, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1983
Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitusJ A Scarlett, O G Kolterman, T P Ciaraldi, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Advanced Drug Delivery Reviews|September 23, 2003
Pegvisomant in the treatment of acromegalyC Parkinson, J A Scarlett, P J Trainer
The American Journal of Physiology|July 1, 1982
Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitusJ M Olefsky, O G Kolterman, J A Scarlett
Annals of Internal Medicine|September 15, 1989
Amiprilose hydrochloride for rheumatoid arthritisW G Riskin, D B Gillings, J A Scarlett
The American Journal of Clinical Nutrition|December 1, 1976
Acute effect of ascorbic acid infusion on carbohydrate toleranceJ A Scarlett, A Zeidler, H Rochman, et al.
The American Journal of Medicine|January 1, 1979
Behçet's syndrome. Report of a case associated with pericardial effusion and cryoglobulinemia treated with indomethacinJ A Scarlett, M L Kistner, L C Yang
The American Journal of Clinical Nutrition|August 1, 1982
Comparison of the metabolic responses to fructose and sucrose sweetened foodsP A Crapo, J A Scarlett, O G Kolterman
The Journal of Clinical Endocrinology and Metabolism|August 18, 2000
Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogsV S Herman-Bonert, K Zib, J A Scarlett, et al.
Diabetes|May 20, 1999
Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in miceA Flyvbjerg, W F Bennett, R Rasch, et al.
Diabetes|October 1, 1982
In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in manR S Gray, J A Scarlett, J Griffin, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1983
Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitusJ A Scarlett, O G Kolterman, T P Ciaraldi, et al.
Pageof 3